Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis

The prognosis and treatment of patients with low-flow (LF) severe aortic stenosis are controversial. The Placement of Aortic Transcatheter Valves (PARTNER) trial randomized patients with severe aortic stenosis to medical management versus transcatheter aortic valve replacement (TAVR; inoperable coho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2013-06, Vol.127 (23), p.2316-2326
Hauptverfasser: HERRMANN, Howard C, PIBAROT, Philippe, BAVARIA, Joseph E, KODALI, Susheel, HAHN, Rebecca T, WILLIAMS, Mathew, CRAIG MILLER, D, DOUGLAS, Pamela S, LEON, Martin B, HUETER, Irene, GERTZ, Zachary M, STEWART, William J, KAPADIA, Samir, MURAT TUZCU, E, BABALIAROS, Vasilis, THOURANI, Vinod, SZETO, Wilson Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The prognosis and treatment of patients with low-flow (LF) severe aortic stenosis are controversial. The Placement of Aortic Transcatheter Valves (PARTNER) trial randomized patients with severe aortic stenosis to medical management versus transcatheter aortic valve replacement (TAVR; inoperable cohort) and surgical aortic valve replacement versus TAVR (high-risk cohort). Among 971 patients with evaluable echocardiograms (92%), LF (stroke volume index ≤35 mL/m(2)) was observed in 530 (55%); LF and low ejection fraction (
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.112.001290